Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
353 Leser
Artikel bewerten:
(2)

Maple Leaf Critical Minerals 2023 Enhanced Flow-Through Limited Partnership - Final Prospectus Filed, Books Closing February 15, 2023 for Initial Closing

Finanznachrichten News

VANCOUVER, BC / ACCESSWIRE / January 31, 2023 / Maple Leaf Critical Minerals 2023 Enhanced Flow-Through Limited Partnership (the "Partnership") is pleased to announce that it has filed a final prospectus (the "Prospectus") dated January 30, 2023 with the securities commissions or similar authorities in each of the Provinces of Canada relating to the initial public offering of units of the Partnership. The books will close on Wednesday, February15, 2023 at 12 noon (EST) for its initial closing on Thursday, February 16, 2023.

Partnership Objectives & Benefits - National Class Units

The Partnership is designed to provide holders of National Class Units ("National Class Limited Partners") with an investment in a diversified portfolio of Flow-Through Shares of Resource Companies incurring Eligible Expenditures (as those terms are defined in the Prospectus) across Canada with a view to maximizing the tax benefits of an investment in National Class Units and achieving capital appreciation and/or income for National Class Limited Partners. National Class Limited Partners must be residents of Canada or liable to pay Canadian income tax.

Investors are expected to receive tax deductions for 2023 of approximately 137% of the amount invested based on and subject to certain conditions as set forth in the Prospectus.

Partnership Objectives & Benefits - Québec Class Units

The Partnership is designed to provide holders of Québec Class Units ("Québec Class Limited Partners") with an investment in a diversified portfolio of Flow-Through Shares of Resource Companies incurring Eligible Expenditures principally in the Province of Québec with a view to maximizing the tax benefits of an investment in Québec Class Units and achieving capital appreciation and/or income for Québec Class Limited Partners. Québec Class Units are most suitable for investors who reside in the Province Québec or are liable to pay income tax in Québec.

Investors are expected to receive tax deductions for 2023 of up to approximately 147% of the amount invested based on and subject to certain conditions as set forth in the Prospectus.

Liquidity Event

The investment portfolios of both the National and Québec Class Units will be actively managed in such a way as to preserve the ability to undertake a future liquidity event, such as a rollover into a mutual fund corporation.

The Syndicate

The syndicate of agents for the offering is being led by Scotia Capital Inc. and includes National Bank Financial Inc., CIBC World Markets Inc., BMO Nesbitt Burns Inc., iA Private Wealth Inc., Richardson Wealth Limited, Canaccord Genuity Corp., Desjardins Securities Inc., Echelon Wealth Partners Inc., Manulife Securities Incorporated, Raymond James Ltd. and Laurentian Bank Securities Inc.

A copy of the Prospectus can be obtained from any agent.

Offering Jurisdictions

Each of the Provinces of Canada.

FOR FURTHER INFORMATION, PLEASE CONTACT

Hugh Cartwright, Chairman

MAPLE LEAF SHORTDURATION FLOW-THROUGH PROGRAMS

Tel: 1-866-688-5750

Email: info@mapleleaffunds.ca Web: www.MapleLeafFunds.ca

www.MapleLeafFunds.ca

A final prospectus dated January 30, 2023 relating to these securities has been filed with the securities commissions or similar authorities in each of the Provinces of Canada. This release shall not constitute an offer to sell or the solicitation of any offer to buy the securities. This release is provided for information purposes only. Commissions, trailing commissions, management fees and expenses all may be associated with investment funds. Please read the Prospectus before investing. Investment funds are not guaranteed, their values change frequently, and past performance may not be repeated. Capitalized terms not defined herein have the meanings set forth in the Prospectus.

SOURCE: Maple Leaf Critical Minerals 2023 Enhanced Flow-Through Limited Partnership

View source version on accesswire.com:
https://www.accesswire.com/737614/Maple-Leaf-Critical-Minerals-2023-Enhanced-Flow-Through-Limited-Partnership--Final-Prospectus-Filed-Books-Closing-February-15-2023-for-Initial-Closing

© 2023 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.